<?xml version='1.0' encoding='utf-8'?>
<document id="15651086"><sentence text="Hydrophilic interaction liquid chromatographic tandem mass spectrometric determination of atenolol in human plasma."><entity charOffset="90-98" id="DDI-PubMed.15651086.s1.e0" text="atenolol" /></sentence><sentence text="A hydrophilic interaction liquid chromatographic method with tandem mass spectrometry for the determination of atenolol, a beta-blocking agent, in human plasma has been developed and validated over the curve range of 10--2000 ng/mL"><entity charOffset="111-119" id="DDI-PubMed.15651086.s2.e0" text="atenolol" /></sentence><sentence text=" The assay was based on protein precipitation followed by evaporation of the extraction solvent, reconstitution with acetonitrile, and chromatography on an Hypersil silica column (50 x 4"><entity charOffset="117-129" id="DDI-PubMed.15651086.s3.e0" text="acetonitrile" /><entity charOffset="165-171" id="DDI-PubMed.15651086.s3.e1" text="silica" /><pair ddi="false" e1="DDI-PubMed.15651086.s3.e0" e2="DDI-PubMed.15651086.s3.e0" /><pair ddi="false" e1="DDI-PubMed.15651086.s3.e0" e2="DDI-PubMed.15651086.s3.e1" /></sentence><sentence text="6 mm) using a low aqueous--high organic mobile phase" /><sentence text=" The mobile phase consists of 85% acetonitrile, 15% water, 0"><entity charOffset="34-46" id="DDI-PubMed.15651086.s5.e0" text="acetonitrile" /></sentence><sentence text="5% acetic acid and 0"><entity charOffset="3-14" id="DDI-PubMed.15651086.s6.e0" text="acetic acid" /></sentence><sentence text="04% trifluoroacetic acid and runs isocratically at a flow rate of 2"><entity charOffset="4-24" id="DDI-PubMed.15651086.s7.e0" text="trifluoroacetic acid" /></sentence><sentence text="0 mL/min" /><sentence text=" The column ef fluent was split so that 50% of it was transferred into the LC-MS/MS interface operated in positive electrospray ionization mode" /><sentence text=" The chromatographic run time was 2" /><sentence text="0 min per injection" /><sentence text=" Atenolol and the internal standard, atenolol-d(7), showed a retention time of 1"><entity charOffset="1-9" id="DDI-PubMed.15651086.s12.e0" text="Atenolol" /></sentence><sentence text="0 min" /><sentence text=" The inter-day and intra-day precision and accuracy of the quality control samples were &lt;5" /><sentence text="3% relative standard deviation and &lt;8" /><sentence text="0% relative error, respectively" /><sentence text=" To explore the application of the current method for the analysis of other beta-blocking agents, propranolol and metoprolol were tested under the same chromatographic conditions with retention times of 0"><entity charOffset="98-109" id="DDI-PubMed.15651086.s17.e0" text="propranolol" /><entity charOffset="114-124" id="DDI-PubMed.15651086.s17.e1" text="metoprolol" /><pair ddi="false" e1="DDI-PubMed.15651086.s17.e0" e2="DDI-PubMed.15651086.s17.e0" /><pair ddi="false" e1="DDI-PubMed.15651086.s17.e0" e2="DDI-PubMed.15651086.s17.e1" /></sentence><sentence text="68 and 0" /><sentence text="75 min, respectively" /><sentence text=" The present method could be used for therapeutic drug monitoring, pharmacokinetic and drug--drug interaction studies of beta-blocking agents" /><sentence text="" /></document>